DTC-In-Perspective by Bob EhrlichDTC in Perspective: Advertising New IndicationsFebruary 27, 2015 by Bob Ehrlich0 Author Bob Ehrlich Related posts: DTC in Perspective: States Push For Drug Development Cost Disclosure There are no doubt some very expensive prescription drugs that... DTC in Perspective: Pradaxa Comes Back to Television Welcome back to Pradaxa, a drug to prevent stroke, with... DTC in Perspective: DTC Might Be Imperfect, But Still Important for Patients Drug companies defend DTC by arguing it creates disease awareness... DTC in Perspective: The People of DTC As I sat through the many DTC presentations last week... Bob Ehrlich
